COVID-19: Get the latest updates or take a self-assessment.
Patients with heavy menstrual bleeding are provided with information on all potential treatment options and are supported in making an informed decision on the most appropriate treatments for them, based on their values, preferences, and goals, including their desire for future fertility.
Shared decision-making involves a partnership between the clinician and the patient. The health care professional brings clinical expertise to the discussion while the patient brings knowledge about the impact the heavy menstrual bleeding is having on their life and about their goals for treatment. To facilitate informed shared decision-making about treatment, clinicians should provide patients with accurate information about the range of normal menstrual bleeding and all potential treatment options for the patient’s specific case. Patients should receive information on the treatment objectives, side effects, risks, impact on fertility, and anticipated out-of-pocket costs of all potential treatment options.
You should decide what treatment you prefer after discussing all the options with your health care professional. You should be told about any side effects, risks, effects on your ability to get pregnant, and out-of-pocket costs.
Provide patients with information on all potential treatment options and help them make a decision consistent with their values and preferences.
Ensure systems, processes, policies, and resources are in place such that patients have access to their treatment of choice.
Percentage of patients with heavy menstrual bleeding who reported that they received information from their health care professional about treatment options, including information on treatment objectives, side effects, risks, impact on fertility, and potential out-of-pocket costs of each option
Denominator: number of patients with heavy menstrual bleeding
Numerator: number of patients with heavy menstrual bleeding who reported that they received information from their health care professional about their treatment options, including information on:
Treatment objectives
Side effects
Risks
Impact on fertility
Potential out-of-pocket costs
Data source: local data collection
Note: The indicator can be calculated as an overall percentage and by each listed component.
Percentage of patients with heavy menstrual bleeding who reported that they received their preferred treatment option
Numerator: number of patients with heavy menstrual bleeding who reported that they received their preferred treatment option
Patients, families and the public are central to improving health quality.
Are you passionate about quality health care for all Ontarians? Stay in-the-know about our newest programs, reports and news.